Oncology Pharma Inc. (ONPH)
USD 0.0
(100.0%)
USD 0.0
(100.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2004 |
|---|---|---|---|---|---|---|
| Total Assets | - | 2.12 Million | 347.55 Thousand | 230.85 Thousand | 190.54 Thousand | 48 Thousand |
| Total Current Assets | - | 3964.00 | 8954.00 | 1805.00 | 6708.00 | 48 Thousand |
| Cash And Short Term Investments | - | 3964.00 | 8954.00 | 1805.00 | 6708.00 | 8000.00 |
| Cash and Cash Equivalents | - | 3964.00 | 8954.00 | 1805.00 | 6708.00 | 8000.00 |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | 19 Thousand |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - | 21 Thousand |
| Total Non-Current Assets | - | 2.11 Million | 338.59 Thousand | 229.05 Thousand | 183.83 Thousand | - |
| Net PPE | - | - | - | 779.00 | 1888.00 | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | 2.11 Million | 338.6 Thousand | 228.27 Thousand | 181.94 Thousand | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | -1.00 | - | 1.00 | - |
| Other Assets | - | - | 1.00 | - | - | - |
| Total Liabilities | - | 875.47 Thousand | 517.56 Thousand | 294.51 Thousand | 403.15 Thousand | 220 Thousand |
| Total Current Liabilities | - | 875.47 Thousand | 517.56 Thousand | 294.51 Thousand | 403.15 Thousand | 220 Thousand |
| Account Payables | - | - | - | - | - | 195 Thousand |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | 662.08 Thousand | 238.38 Thousand | 129.41 Thousand | 238.05 Thousand | 25 Thousand |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | - | 213.38 Thousand | 279.18 Thousand | 165.1 Thousand | 165.1 Thousand | - |
| Total Non Current Liabilities | - | - | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | - | 1.24 Million | -170.01 Thousand | -63.66 Thousand | -212.61 Thousand | - |
| Stock Holders Equity | - | 1.24 Million | -170.01 Thousand | -63.66 Thousand | -212.61 Thousand | -172 Thousand |
| Common Stock | - | 188.89 Thousand | 182.46 Thousand | 150.14 Thousand | 124.89 Thousand | 13 Thousand |
| Retained Earnings | - | -272.09 Million | -167.47 Million | -69.99 Million | -69.79 Million | -25.56 Million |
| Accumulated other comprehensive income | - | -188.89 Thousand | -182.47 Thousand | -150.14 Thousand | 100 Thousand | - |
| Common Stock Equity | - | 1.24 Million | -170.01 Thousand | -63.66 Thousand | -212.61 Thousand | -172 Thousand |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | 2.11 Million | 338.6 Thousand | 228.27 Thousand | 181.94 Thousand | - |
| Total Debt | - | 662.08 Thousand | 238.38 Thousand | 129.41 Thousand | 238.05 Thousand | 25 Thousand |
| Net Debt | - | 658.12 Thousand | 229.43 Thousand | 127.6 Thousand | 231.34 Thousand | 17 Thousand |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Total Assets | - | - | - | - | 2.13 Million | 2.14 Million |
| Total Current Assets | - | - | - | - | 398.00 | 1783.00 |
| Cash And Short Term Investments | - | - | - | - | 398.00 | 1783.00 |
| Cash and Cash Equivalents | - | - | - | - | 398.00 | 1783.00 |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - | - |
| Total Non-Current Assets | - | - | - | - | 2.13 Million | 2.13 Million |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | 2.13 Million | 2.13 Million |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - | - |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | 1.03 Million | 1.01 Million |
| Total Current Liabilities | - | - | - | - | 1.03 Million | 1.01 Million |
| Account Payables | - | - | - | - | - | - |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | - | - | - | 777.62 Thousand | 773.22 Thousand |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | 261.08 Thousand | 242.99 Thousand |
| Total Non Current Liabilities | - | - | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | - | - | - | - | 1.1 Million | 1.12 Million |
| Stock Holders Equity | - | - | - | - | 1.1 Million | 1.12 Million |
| Common Stock | - | - | - | - | 193.69 Thousand | 193.09 Thousand |
| Retained Earnings | - | - | - | - | -277.69 Million | -277.44 Million |
| Accumulated other comprehensive income | - | - | - | - | -193.69 Thousand | -193.09 Thousand |
| Common Stock Equity | - | - | - | - | 1.1 Million | 1.12 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | 2.13 Million | 2.13 Million |
| Total Debt | - | - | - | - | 777.62 Thousand | 773.22 Thousand |
| Net Debt | - | - | - | - | 777.22 Thousand | 771.43 Thousand |
S32
002350
300602
ERO
301211
FBU